SCHEMBL7974441

SCHEMBL7974441

Oc1nc(-c2ccncc2)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK2 P25098 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
ALDH1A1 P00352 2/20 0.42
HTR6 P50406 1/20 0.41
HPGDS O60760 1/20 0.40
HPGD P15428 1/20 0.40
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
ADORA2A P29274 1/20 0.40
DHPS P49366 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
KCNH2 Q12809 1/20 0.39
DYRK1A Q13627 1/20 0.39
GAA P10253 2/20 0.38
PARN O95453 1/20 0.38
CNOT7 Q9UIV1 1/20 0.38
TNF P01375 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975267 0.92 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1HPGDSHPGDADORA2A
SCHEMBL7988558 0.89 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1HPGDSHPGDADORA2A
SCHEMBL7974267 0.89 SMN1; SMN2 (0.43) GRK2SMN1; SMN2HTR6HPGDKMT2A
SCHEMBL7991678 0.88 HTT (0.40) SMN1; SMN2ALDH1A1ADORA2AKMT2ACNOT7
SCHEMBL7985826 0.88 NPC1 (0.41) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7985275 0.88 MET (0.46) DYRK1ACNOT7CYP11B1CYP11B2
SCHEMBL7984459 0.88 NR1H2 (0.43) SMN1; SMN2ALDH1A1HPGDSHPGDADORA2A
SCHEMBL7975133 0.88 ADORA2A (0.50) SMN1; SMN2ALDH1A1HPGDSHPGDADORA2A
SCHEMBL7974286 0.87 DHPS (0.49) SMN1; SMN2ALDH1A1HPGDSDHPSKMT2A
SCHEMBL7974507 0.86 MET (0.46) SMN1; SMN2ALDH1A1HPGDSHPGDADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed